| scholarly article | Q13442814 |
| P50 | author | Jesus Blazquez | Q68273789 |
| Juan A Ayala | Q87052478 | ||
| Carlos Juan | Q41183643 | ||
| P2093 | author name string | Antonio Oliver | |
| Bartolomé Moya | |||
| Laura Zamorano | |||
| Gabriel Cabot | |||
| Gabriel Torrens | |||
| Marcelo Pérez-Gallego | |||
| Marta Munar-Bestard | |||
| P2860 | cites work | A peptidoglycan recognition protein in innate immunity conserved from insects to humans | Q24324731 |
| The fitness costs of antibiotic resistance mutations | Q26825334 | ||
| Functions of Peptidoglycan Recognition Proteins (Pglyrps) at the Ocular Surface: Bacterial Keratitis in Gene-Targeted Mice Deficient in Pglyrp-2, -3 and -4 | Q27320064 | ||
| Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria | Q27644338 | ||
| The Development of Selective Inhibitors of NagZ: Increased Susceptibility of Gram-Negative Bacteria to β-Lactams | Q27679877 | ||
| A Fluorescent Transport Assay Enables Studying AmpG Permeases Involved in Peptidoglycan Recycling and Antibiotic Resistance. | Q51626717 | ||
| The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo | Q79755027 | ||
| Human peptidoglycan recognition proteins require zinc to kill both gram-positive and gram-negative bacteria and are synergistic with antibacterial peptides | Q79803387 | ||
| Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase | Q28115452 | ||
| Pseudomonas aeruginosa: all roads lead to resistance | Q28240246 | ||
| Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection | Q28472320 | ||
| A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria | Q28472390 | ||
| Reactions of the three AmpD enzymes of Pseudomonas aeruginosa | Q28493213 | ||
| Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan | Q28511228 | ||
| Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress | Q28540887 | ||
| PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation | Q28587573 | ||
| An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants | Q29614860 | ||
| Peptidoglycan recognition proteins are a new class of human bactericidal proteins | Q29871532 | ||
| Enhanced antimicrobial activity of engineered human lysozyme | Q30496665 | ||
| Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci | Q30833136 | ||
| A scavenger function for a Drosophila peptidoglycan recognition protein. | Q31122252 | ||
| Biological cost of AmpC production for Salmonella enterica serotype Typhimurium | Q33594641 | ||
| Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections | Q33728266 | ||
| The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase | Q33832428 | ||
| The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. | Q34167642 | ||
| Killing of gram-negative bacteria by lactoferrin and lysozyme | Q34202613 | ||
| Peptidoglycan recognition proteins: modulators of the microbiome and inflammation | Q34231836 | ||
| Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii | Q34346016 | ||
| Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions | Q34579070 | ||
| Lysozymes in the animal kingdom | Q34659960 | ||
| What's new in lysozyme research? Always a model system, today as yesterday | Q34662013 | ||
| AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains | Q34933120 | ||
| Nosocomial infections in adult intensive-care units | Q35157647 | ||
| A novel peptidoglycan binding protein crucial for PBP1A-mediated cell wall biogenesis in Vibrio cholerae | Q35191261 | ||
| Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems | Q35222641 | ||
| Deception point: peptidoglycan modification as a means of immune evasion | Q35612173 | ||
| The cell wall amidase AmiB is essential for Pseudomonas aeruginosa cell division, drug resistance and viability | Q36283107 | ||
| A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence | Q36668852 | ||
| Intracellular NOD-like receptors in host defense and disease | Q36984454 | ||
| Recombinant Human Peptidoglycan Recognition Proteins Reveal Antichlamydial Activity | Q37073988 | ||
| The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis | Q37081708 | ||
| Mammalian PGRPs in the spotlight | Q37393519 | ||
| Pseudomonas genomes: diverse and adaptable | Q37848453 | ||
| Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis | Q37925062 | ||
| Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway. | Q37961906 | ||
| Mammalian peptidoglycan recognition proteins kill bacteria by activating two-component systems and modulate microbiome and inflammation | Q37995300 | ||
| Pseudomonas aeruginosa: new insights into pathogenesis and host defenses | Q38101888 | ||
| Everything old is new again: an update on current research on the Cpx envelope stress response | Q38159109 | ||
| Different walls for rods and balls: the diversity of peptidoglycan | Q38176980 | ||
| Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway? | Q38802410 | ||
| Considerations and caveats in anti-virulence drug development | Q38810589 | ||
| Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development | Q38844899 | ||
| Fine-Tuning of the Cpx Envelope Stress Response Is Required for Cell Wall Homeostasis in Escherichia coli | Q39002301 | ||
| Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response | Q39195877 | ||
| Cryo-Transmission Electron Microscopy of Frozen-Hydrated Sections ofEscherichia coliandPseudomonas aeruginosa | Q39997774 | ||
| Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa | Q40401711 | ||
| Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure. | Q41036103 | ||
| Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk | Q41340539 | ||
| The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence | Q41576665 | ||
| Role of mouse peptidoglycan recognition protein PGLYRP2 in the innate immune response to Salmonella enterica serovar Typhimurium infection in vivo | Q41971834 | ||
| Purification of a peptidoglycan recognition protein from hemolymph of the silkworm, Bombyx mori | Q42064170 | ||
| Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues | Q42074076 | ||
| NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa | Q42430253 | ||
| Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa | Q42541439 | ||
| The Cpx envelope stress response modifies peptidoglycan cross-linking via the L,D-transpeptidase LdtD and the novel protein YgaU. | Q42553041 | ||
| Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection | Q42930592 | ||
| A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action | Q43740251 | ||
| High salt stress in Bacillus subtilis: involvement of PBP4* as a peptidoglycan hydrolase. | Q46209797 | ||
| Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli | Q47609428 | ||
| Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. | Q47646856 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | e0181932 | |
| P577 | publication date | 2017-07-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system | |
| P478 | volume | 12 |
| Q88918474 | Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance |
| Q90050433 | Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections |
| Q46286684 | Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. |
| Q57158084 | Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens |
| Q64228706 | Peptidoglycan Recognition Protein 2 Regulates Neutrophil Recruitment Into the Lungs After Infection |
| Q90732948 | Peptidoglycan Recognition Protein 4 Limits Bacterial Clearance and Inflammation in Lungs by Control of the Gut Microbiota |
| Q64065367 | Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins |
| Q91655011 | Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling |
Search more.